Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - Astria Therapeutics, Inc. | tm211035d2_ex32-2.htm |
EX-32.1 - EXHIBIT 32.1 - Astria Therapeutics, Inc. | tm211035d2_ex32-1.htm |
EX-31.2 - EXHIBIT 31.2 - Astria Therapeutics, Inc. | tm211035d2_ex31-2.htm |
EX-31.1 - EXHIBIT 31.1 - Astria Therapeutics, Inc. | tm211035d2_ex31-1.htm |
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Astria Therapeutics, Inc. | tm211035d2_ex23-1.htm |
EX-10.10 - EXHIBIT 10.10 - Astria Therapeutics, Inc. | tm211035d2_ex10-10.htm |
EX-10.9 - EXHIBIT 10.9 - Astria Therapeutics, Inc. | tm211035d2_ex10-9.htm |
EX-10.3 - EXHIBIT 10.3 - Astria Therapeutics, Inc. | tm211035d2_ex10-3.htm |
10-K - 10-K - Astria Therapeutics, Inc. | tm211035-1_10k.htm |
Exhibit 21.1
Subsidiaries of the Registrant
Entity | Jurisdiction of Incorporation | |
Catabasis Securities Corporation | Delaware | |
Quellis Biosciences, LLC. | Delaware |